Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide as adjunctive therapy for uncontrolled partial-onset seizures
CTR20130556Phase 3Active
- Sponsor
- Chongqing Libang Pharmaceutical
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in epilepsy, sponsored by Chongqing Libang Pharmaceutical. Started Feb 2015; status: active.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20130556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130556.